CAMPBELL, CA – May 2, 2019 – Atia Vision, Inc., a Shifamed portfolio company committed to improving patient outcomes through the development of a modular presbyopia-correcting accommodating intraocular lens, announced today initial closing of its committed $20M Series D preferred stock financing. Financing was led by Cormorant Asset Management, with participation by The Capital Partnership (TCP), AMED Ventures and Shangbay Capital. The financing will be used to advance Atia Vision’s clinical efforts.
About schipper-adminThis author has not yet filled in any details.
So far schipper-admin has created 3 blog entries.
CAMPBELL, CA – December 10, 2018 – Atia Vision, Inc., a Shifamed portfolio company committed to improving patient outcomes through the development of a modular accommodating intraocular lens, announced today the closing of its second tranche of a Series C preferred stock financing, raising a total of $10M. Atia Vision’s unique technology enables natural accommodation, utilizing the ciliary muscles of the eye and providing for subsequent refractive correction, to restore the full range of functional vision for cataract patients. Led by The Capital Partnership (TCP), with participation from Medvance Incubator Partners and Cormorant Healthcare Fund, the financing officially closed on November 9, 2018. The funds raised in this round will support Atia Vision’s clinical efforts.
CAMPBELL, CA – May 8, 2017 – Atia Vision, a privately held medical device company focused on developing an accommodating intraocular lens to address the unmet clinical needs in the intraocular market, today announced it has closed $4M in the first tranche of its Series C financing.